Cargando…

A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma

BACKGROUND: Glioma is the most common central nervous malignancy. Due to its poor survival outcomes, it is essential to identify novel individualized therapy. Oncolytic virus (OV) treatment is a key therapy regulating tumor microenvironment in malignant glioma. Herein, we aim to identify the key gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Zheng, Yin, Xiaofeng, Ding, Rui, Chen, Laizhao, Hao, Chunyan, Duan, Hubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556503/ https://www.ncbi.nlm.nih.gov/pubmed/37808305 http://dx.doi.org/10.3389/fmicb.2023.1249289

Ejemplares similares

ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas
por: Li, Jinchuan, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma
por: Zhang, Yi, et al.
Publicado: (2023)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis
por: Hao, Chunyan, et al.
Publicado: (2018)

Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas
por: Hao, Chunyan, et al.
Publicado: (2017)

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas
por: Liu, Liling, et al.
Publicado: (2021)

Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling
por: Wu, Quansheng, et al.
Publicado: (2021)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023)

Molecular mechanism of m(6)A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells
por: Wu, Quansheng, et al.
Publicado: (2022)

Identification of novel prognostic targets in glioblastoma using bioinformatics analysis
por: Yin, Xiaofeng, et al.
Publicado: (2022)

Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023)

Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
por: Li, Junsheng, et al.
Publicado: (2022)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023)

Immune‐related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients
por: Yu, Hao, et al.
Publicado: (2022)

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

Oncolytic Bluetongue Viruses: Promise, Progress, and Perspectives
por: Li, Joseph K.-K.
Publicado: (2011)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma
por: Guo, Qingbao, et al.
Publicado: (2023)

CENP-A is a potential prognostic biomarker and correlated with immune infiltration levels in glioma patients
por: Yang, Yuan, et al.
Publicado: (2022)

Development and application of oncolytic viruses as the nemesis of tumor cells
por: Zhu, Xiao, et al.
Publicado: (2023)

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma
por: Tu, Binfeng, et al.
Publicado: (2022)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Comprehensive analysis of histone deacetylases genes in the prognosis and immune infiltration of glioma patients
por: Shen, Lin, et al.
Publicado: (2022)

The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration
por: Wang, Xu, et al.
Publicado: (2022)

Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
por: Li, Yao, et al.
Publicado: (2023)

The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas
por: Song, Jingjing, et al.
Publicado: (2023)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

IFI30 as a prognostic biomarker and correlation with immune infiltrates in glioma
por: Jiang, Wei, et al.
Publicado: (2021)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
por: Wang, Feng, et al.
Publicado: (2022)

PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma
por: Zhang, Wei, et al.
Publicado: (2023)

Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?
por: Su, Kar Yan, et al.
Publicado: (2019)

CLP1 is a Prognosis-Related Biomarker and Correlates With Immune Infiltrates in Rheumatoid Arthritis
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Ceruloplasmin is associated with the infiltration of immune cells and acts as a prognostic biomarker in patients suffering from glioma
por: Jia, Miaomiao, et al.
Publicado: (2023)

Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
por: Zhao, Yaqi, et al.
Publicado: (2021)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
por: Li, Jinna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_99dvm3msrfran9sd7gqf0uoepk